Hematologic Malignancy Clinical Trials in Memphis, Tennessee
7 recruitingMemphis, Tennessee
Showing 1–7 of 7 trials
Recruiting
Phase 1
CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma
Hematologic MalignancyRelapsed Pediatric ALLHematopoietic Cell Transplantation
St. Jude Children's Research Hospital60 enrolled1 locationNCT07257419
Recruiting
Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy
Solid TumorHematologic MalignancyB-ALL
St. Jude Children's Research Hospital100 enrolled3 locationsNCT06579469
Recruiting
Phase 1
CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies
LymphomaMDSHematologic Malignancy+2 more
St. Jude Children's Research Hospital18 enrolled1 locationNCT06326463
Recruiting
Response to Influenza Vaccination in Pediatric Oncology Patients
Hematologic MalignancyPediatric CancerTransplant-Related Cancer
St. Jude Children's Research Hospital150 enrolled1 locationNCT05384288
Recruiting
Phase 1
TCRαβ-depleted Progenitor Cell Graft With Early Memory T-cell DLI, Plus Selected Use of Blinatumomab, in naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies
Hematologic Malignancy
St. Jude Children's Research Hospital30 enrolled1 locationNCT07052370
Recruiting
Long-term Follow-up After Adoptive Transfer of Genetically Modified Cell Products
Relapsed Hematologic MalignancyRefractory Hematologic Malignancy
St. Jude Children's Research Hospital1,000 enrolled1 locationNCT05713214
Recruiting
Phase 1
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
Hodgkin LymphomaAMLMDS+8 more
Therapeutic Advances in Childhood Leukemia Consortium54 enrolled31 locationsNCT05476770